These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1566416)

  • 1. Correlation of xenografting results using different organ systems: differential value of xenograft organ testing.
    Thomas F; Araneda D; Pittman K; Marchman W; DeMasi R; Quarantillo P; Thomas J
    Transplant Proc; 1992 Apr; 24(2):525-6. PubMed ID: 1566416
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of immunosuppressive drugs in xenografting.
    Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
    Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
    [No Abstract]   [Full Text] [Related]  

  • 3. Extended and expanded studies of xenograft rejection in immunodeficient animals.
    Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
    Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations of the validity of mouse-to-rat xenograft combinations in xenograft testing.
    Araneda D; Moon S; Pittman K; Thomas F
    Transplant Proc; 1994 Jun; 26(3):1228-9. PubMed ID: 8029896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 7. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 9. Suramin as an anticomplementary agent in xenotransplantation.
    Carobbi A; Di Stefano R; Danesi R; Carmellini M; Ferrari M; Galatioto C; Ermini M; Mosca F
    Transplant Proc; 1992 Apr; 24(2):700. PubMed ID: 1566488
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic and xenogeneic cross-reactions in hyperimmune recipients.
    Di Stefano R; Carobbi A; Frosini F; Scavuzzo M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):446. PubMed ID: 8438372
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary allogeneic challenge of xenotransplant recipients.
    Di Stefano R; Carobbi A; Frosini F; Ferrari M; Pelosi W; Rizzo G; Ermini M; Mosca F
    Transplant Proc; 1992 Apr; 24(2):694-5. PubMed ID: 1566485
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac hyperacute rejection in concordant xenograft combinations induced by immunization.
    Wu GD; Cramer DV; Chapman FA; Wang HK; Hreha G; Ulker N; Makowka L
    Transplant Proc; 1992 Apr; 24(2):691-2. PubMed ID: 1566483
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression in xenotransplantation.
    Hammer C
    Transplant Proc; 1996 Dec; 28(6):3017-20. PubMed ID: 8962171
    [No Abstract]   [Full Text] [Related]  

  • 16. Retransplantation after heart xenografting.
    Gannedahl G; Karlsson-Parra A; Tötterman TH; Tufveson G
    Transplant Proc; 1992 Apr; 24(2):693. PubMed ID: 1566484
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse).
    Zeng Y; Bluestone JA; Ildstad ST; Torres MA; Montag AG; Thistlethwaite RJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):438-9. PubMed ID: 8438368
    [No Abstract]   [Full Text] [Related]  

  • 18. Splenectomy is a potent immunosuppressive modality for cardiac xenografting.
    Carobbi A; Araneda D; Thomas F; Quarantillo P; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):419-20. PubMed ID: 8438360
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunobiology of the xenograft response: xenograft rejection in immunodeficient animals.
    Thomas FT; Marchman W; Carobbi A; Araneda D; Pryor W; Thomas J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):208-9. PubMed ID: 1990514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indefinite acceptance of heart but not skin or islet allografts in rats by total lymphoid irradiation without intrathymic injection of donor cells.
    Papalois B; Wahoff D; Aasheim T; Griffin R; Nelson L; Field J; Sutherland DE
    Transplant Proc; 1995 Dec; 27(6):3190. PubMed ID: 8539905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.